What's 'mean­ing­ful' phar­ma in­no­va­tion? House sub­com­mit­tee talks in­cen­tives

The health sub­com­mit­tee of the House Ways and Means Com­mit­tee heard tes­ti­mo­ny on Wednes­day from five wit­ness­es, in­clud­ing ad­vo­cates and doc­tors, while ex­am­in­ing fed­er­al poli­cies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER